Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | ANXA2P2 |
Upstream (Parents) |
---|
(<<) LAMC2 → ANXA2P2 |
(<<) MAFF → ANXA2P2 |
(<<) PLAUR → ANXA2P2 |
(<<) S100A11P1///S100A11 → ANXA2P2 |
Downstream (Children) |
---|
ANXA2P2 → KLK6 (>>) |
ANXA2P2 → TTC9 (>>) |
ANXA2P2 → IL11 (>>) |
ANXA2P2 → MYO7A (>>) |
ANXA2P2 → TFAP2A (>>) |
ANXA2P2 → CHRNA1 (>>) |
ANXA2P2 → LAMA3 (>>) |
ANXA2P2 → FOSL1 (>>) |
ANXA2P2 → PREX2 (>>) |
ANXA2P2 → TRIP6 (>>) |
ANXA2P2 → COL13A1 (>>) |
ANXA2P2 → S100A11P1///S100A11 (>>) |
ANXA2P2 → LIF (>>) |
ANXA2P2 → NAAA (>>) |